Controlled Transdermal Release of Antioxidant Ferulate by a Porous Sc(III) MOF

iScience. 2020 Jun 26;23(6):101156. doi: 10.1016/j.isci.2020.101156. Epub 2020 May 11.

Abstract

The Sc(III) MOF-type MFM-300(Sc) is demonstrated in this study to be stable under physiological conditions (PBS), biocompatible (to human skin cells), and an efficient drug carrier for the long-term controlled release (through human skin) of antioxidant ferulate. MFM-300(Sc) also preserves the antioxidant pharmacological effects of ferulate while enhancing the bio-preservation of dermal skin fibroblasts, during the delivery process. These discoveries pave the way toward the extended use of Sc(III)-based MOFs as drug delivery systems (DDSs).

Keywords: Chemistry; Inorganic Chemistry; Materials Structure; Medicine.